Get started
THX PharmaTHX PharmaTHX Pharma

THX Pharma

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonals

Chart


Full chart

Key stats


Market capitalization
‪26.49 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.345 EUR
Net income (FY)
‪−1.77 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪7.60 M‬
Beta (1Y)
−0.33

About THX Pharma


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Mathieu Bernard Mari Charveriat
Website
theranexus.com
Headquarters
Lyon
Founded
2013
ISIN
FR0013286259
FIGI
BBG00HYCJ4F3
IPO date
Oct 30, 2017
IPO offer price
18.31 USD
THX Pharma engages in the design and development of drug candidates affecting the interaction between neurons and glial cells. It offers psychotropic drugs for the treatment of neurological disorders such as narcolepsy, Parkinson's disease, Alzheimer's disease, neuropathic pain, psychiatric conditions, and epilepsy. The company was founded by Franck Joseph Louis Mouthon and Mathieu Bernard Mari Charveriat on March 19, 2013 and is headquartered in Lyon, France.

Check out other big names from the same industry as ALTHX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALTHX is 1.925 EUR — it has increased by 1.05% in the past 24 hours. Watch THX Pharma stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange THX Pharma stocks are traded under the ticker ALTHX.
ALTHX stock has risen by 0.79% compared to the previous week, the month change is a −28.24% fall, over the last year THX Pharma has showed a 295.67% increase.
ALTHX reached its all-time high on Jan 18, 2021 with the price of 22.690 EUR, and its all-time low was 0.250 EUR and was reached on Apr 7, 2025. View more price dynamics on ALTHX chart.
See other stocks reaching their highest and lowest prices.
ALTHX stock is 10.86% volatile and has beta coefficient of −0.33. Track THX Pharma stock price on the chart and check out the list of the most volatile stocks — is THX Pharma there?
Today THX Pharma has the market capitalization of ‪26.49 M‬, it has increased by 3.68% over the last week.
Yes, you can track THX Pharma financials in yearly and quarterly reports right on TradingView.
ALTHX net income for the last half-year is ‪−1.07 M‬ EUR, while the previous report showed ‪−1.87 M‬ EUR of net income which accounts for 42.55% change. Track more THX Pharma financial stats to get the full picture.
No, ALTHX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALTHX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THX Pharma stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THX Pharma technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THX Pharma stock shows the buy signal. See more of THX Pharma technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.